You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available [see all tables in this series...]

Part (ii) Primary drug type used (percent of new clients using) and of those, the percent injecting it

Country		Opioids	% inj	Cocaine	% inj	Amphe tamines	% inj	Ecstasy	Halluci nogens	% inj	Cannabis	Others	% Injecting main drug
Bulgaria		87.1	71.4	0.8	0.0	1.8	14.3	0.2	0.0		9.3	0.8	62.3
Czech Republic		16.1	85.3	0.1	20.0	59.7	78.9	0.4	0.3	9.1	20.5	2.9	60.6
Denmark		18.5	16.5	9.3	2.5	10.4	1.6	2.0	0.1	0.0	52.6	7.1	3.8
Germany	(1)	21.4	37.9	7.2	11.7	9.4	0.5		0.2		58.0	3.8	8.0
Ireland		36.6	32.8	13.9	1.5	1.1	0.0	4.6	0.2	0.0	40.2	3.4	12.2
Greece		84.7	43.0	2.9	4.8			0.1	0.1		10.1	2.1	36.6
Spain	(2)	21.8	12.3	53.9	4.7	0.9	0.0	0.7	0.1	0.0	20.3	2.3	5.1
France		20.2	13.3	3.9	7.7	0.2	0.0	1.1	1.3	0.0	67.3	6.0	4.7
Italy		46.4	46.2	26.5	6.2	0.1		0.8	0.1		24.1	2.0	23.1
Cyprus		42.1	64.8	12.9	7.4	0.5	0.0	1.0	1.0	0.0	40.2	2.3	27.5
Latvia	(3)	33.6		0.5		23.8		1.8	0.5		17.0	22.8	51.5
Lithuania	(4)	77.4	76.2	0.3	0.0	4.9	2.9		0.0		0.3	17.1	91.1
Luxembourg	(5)	70.0	67.9	17.0	52.5	1.0		3.0			7.0	2.0	56.7
Hungary		8.0	60.0	1.0	9.0	6.0	10.0	5.0	1.0		52.0	27.0	6.0
Malta		63.0	69.0	11.0	12.0			2.0			18.0	6.0	47.5
Netherlands		9.6	9.3	34.5	0.6	7.0	0.7	2.1	0.2		41.8	4.8	1.1
Austria	(6)	100.0	100.0	0.0		0.0		0.0	0.0		0.0	0.0
Poland	(7)	19.8		1.2		11.9			0.8		4.4	61.9
Portugal	(8)	77.3		8.1				0.4	0.1		11.4	2.7	20.1
Romania		53.6	91.2	0.6	0.0	0.2	0.0	1.7	0.0		4.3	39.7	49.0
Slovenia	(9)	77.6	64.2	1.1	16.7	0.2	0.0	1.0	0.0		19.6	0.5	50.1
Slovakia		27.5	73.1	0.5	20.0	30.1	33.6	0.3	0.6		28.8	12.2	32.0
Finland		25.0	69.0			29.0	73.0				34.0	12.0	40.0
Sweden		19.0	22.7	3.7	2.2	24.9	41.3	0.7	0.1		31.6	20.0	14.9
United Kingdom	(10)	52.8	37.7	14.2	3.3	4.1	18.6	1.4	0.2		21.9	5.4	21.1
Turkey		38.4	49.2	4.7		0.1	100.0	7.3			28.7	20.8	19.4

Notes:

Data were not available for: Belgium, Estonia, Norway.

When proportion of clients by main drug is 0, % of injectors is blank. If no data is available, the cell is left blank.

(1) Last data available refer to 1999.

(1) Data on amphetamines include amphetamines and ecstasy.

(2) Last data available refer to 2004.

(3) No data on injecting rates for 2005.

(4) Amphetamines rates refer to stimulants in general.

(5) Data on first treatments were not reported in 2005 as the figures were too small. Data refer to all treatments.

(6) Data refer to clients in substitution treatment only; figures for opioids as main drug and injecting use are 100%.

(7) Last data available refer to 2003. Amphetamines refer to amphetamines+ ecstasy.

(8) No data on injection available for 2005. Cocaine includes cocaine+freebase.

(9) Last data available refer to 2004.

(10) Data relate to the period from 1 April 2003 to 31 March 2004 for UK.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Standard Table 3 See [Table TDI-1] for details on sources.